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Introduction 
 Certain populations such as chemotherapy patients and atomic bomb survivors have been 
exposed to ionizing radiation and experience tissue damage and cancer initiation and progression. One 
cancer that can be initiated from radiation is esophageal squamous cell carcinoma (ESCC), an epithelial 
cancer that has a survival rate as low as 20% (Chunping et al., 2009). Researchers have found that when 
protein tyrosine kinase receptors (RPTK) activate oncogenes, they can create epithelial tumors and 
cause deadly cancers like ESCC (Tannock et al., 2005). The RPTK family has one group, MET, that has only 
two receptors, MET and RON, present in the human body. MET’s ligand is the hepatocyte growth factor 
(HGF) and RON’s ligand is the macrophage-stimulating protein (MSP-1). Both HGF and MSP-1 have been 
shown to activate their receptors and are implicated  in certain processes [What processes are these?] 
(Wang et al., 2003). Since radiation damages cells throughout the biological system (Camphausen et. al, 
2001), researchers are investigating whether or not HGF and MSP-1 protects or kills certain normal and 
cancerous cells by being part of cell recovery processes.  
 One research group recently reviewed that the HGF-MET pathway has an important role in the 
embryonic development in the liver, migration of myogenic precursor cells, regulation of epithelial 
morphogenesis and growth, and regeneration and protection in tissues (Nakamura et. al, 2011). In 
addition, since the RON receptor is more commonly expressed in cells of epithelial origin, and when 
activated is part of epithelial cell matrix invasion, dissociation, and migration processes, scientists 
conclude that RON might be one of the factors causing epithelial cancer initiation in the biological 
system (Wang et. al, 2003). In order to examine HGF and MSP-1’s effect on cancer initiation and 
progression we used two immortalized esophageal epithelial cell lines. One  is a  normal human cell line 
(EPC2-hTERT), while the other had a p53 mutation at the 175th amino acid position (EPC2-hTERT-
p53R175H). For this investigation, we used 0(control), 2, and 4 Gray doses of gamma (Cs137) radiation and 
selected various concentrations from 0-100 ng/mL of HGF and MSP-1 in our assays.  
https://ntrs.nasa.gov/search.jsp?R=20110020317 2019-08-30T17:49:49+00:00Z
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 Since the HGF and MSP-1 pathways have proliferative roles in epithelial cells, we conducted the 
MTT proliferation assay to see if either drug enhances or inhibits cell proliferation over time. Also, a MTT 
cytotoxicity assay was necessary to observe whether the drugs are protecting the cells from radiation 
and if a trend is occurring depending upon the amount of dose added. In addition, a wound healing 
assay was done since both drugs have been to known to promote cell motility.  Since cell damage occurs 
when radiation is added, apoptosis and micronuclei assays are vital to see if HGF and MSP-1 increase or 
decrease cell death and damage in normal and pre-cancerous cells and by how much based on the 
radiation dosage. Overall, we used the MTT, wound healing, apoptosis and micronuclei assays to 
investigate the effects ofHGF and MSP-1 on irradiated esophageal epithelial cells. 
Materials and Methods 
 Cell Lines: Normal (EPC2-hTERT) and mutated (EPC2-hTERT-p53R175H) esophageal 
epithelial cell lines were used this investigation. The cells were cultured and maintained 
according to the Phelan, 1998 cell culture protocol. 
 Radiation Dosages: The gamma (Cs137) radiation doses ranged from 0-4 Gys. (0-400 
rads). 
 Drugs: Hepatocyte growth factor (HGF) and macrophage-stimulating protein (MSP-1) 
concentrations ranged from 10-100 ng/mL depending on the assay. 
 Incubation Settings: 37° Celsius, 5% CO2, 98% humidity 
 Controls: No drug or cells with KBM (keratinocyte basal medium) 
 4 assays: MTT Proliferation and Cytotoxicity, Wound Healing, Micronuclei assay, and 
Apoptosis Assay 
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1. MTT Proliferation and Cytotoxicity 
Materials: 
 7 (4 for proliferation and 3 for cytotoxicity) 96-well plates 
 MTT Solvent: 4mM HCl, 0.1% Nandet P-40 (NP40) all in isopropanol 
 MTT Reagant*: (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) 
 PBS solution 
 Aluminum/tin foil 
 TECAN Spectroflorometer 
*Reagant is prepared with a concentration 5 mg/mL in PBS and is covered with foil 
Methods: 
1. Culture the cells (2000 cells/well) with KSFM (keratinocyte serum free medium) in the 
plates and incubate for 24 hours.  
2. Add HGF and MSP-1 (10, 50, and 100 ng/ml) in each well according to the plate setup of 
both proliferation and cytotoxicity assays. Incubate again for 24 hours. 
Proliferation: 
1. Take one plate for the 24 hour reading and add 20 µL of the 5 mg/mL MTT Reagent 
per well. After putting it on the shaker for a few minutes, incubate it for 3.5 hours. 
2. Remove the media from the wells and add 150 µL MTT solvent per well quickly since 
the plate is photosensitive. Put it on the shaker for 15 minutes. 
3. Read the plate by using the TECAN spectrofluorometer.  
4. At 48, 72, and 96 hours, repeat the same steps taken for the 24 hour reading. 
Cytotoxicity: 
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1. Irradiate one plate each at 0, 2, and 4 Gray doses.  
2. After 72 hours, repeat the same steps taken for the 24 hour proliferation plate for 
the 3 cytotoxicity plates.  
Analysis: 
To test how many live cells were present over the 96-hour or 72-hour period, we measured the 
intensity of the purple formazan color, which is produced when living mitochondria converts 
the yellow MTT reagent to purple by using enzymes during the 3.5 hour incubation period. The 
TECAN spectroflorometer then uses an absorbance at an optical density of 590 nm to measure 
this intensity and give values. For the proliferation assay, we can observe if HGF and/or MSP-1 
promotes cell proliferation without any stress added to the experiment. In the cytotoxicity 
assay, we are adding the radiation factor to see if at one particular time if either drug protects 
both types of cells (Wallert and Provost Lab, 2007).  
2. Wound Healing 
Materials: 
•  3 24-well plates (2 with no radiation and 1 with a dose of 2 Gray) 
• Camera 
• PBS solution 
• 200 µL pipette tip 
• Marker with a visible color as biomarker 
• Media that contains KBM with HGF or MSP-1 (both drugs at 50 ng/mL) 
Methods: 
1. Draw a line with a marker on the bottom of each well 
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2. Use the tip to scratch once on each well to create a wound 
3. Rinse the whole plate of cells with PBS solution 
4. Replace the PBS solution with 1.5 mL of media containing the drug  
5. Take a picture of each well at 0, 3, 6, 9, 12, and 24 hrs. 
. [This is not the case – media was left on the whole time] 
Analysis: 
We used Image J (NIH) to measure the length of the wound from each picture taken**. After 
drawing two lines parallel to each other where the cells are bordered and one line connecting 
both perpendicularly, the software measures the length of the gap between the two sides of 
cells. We can then plot these values and find the percentage of the wound healed. For example, 
if 100% is the percentage at 24 hours, it means that the drug facilitated the cells to migrate and 
fill the gap completely over 24 hours. The wound assay can help us determine whether HGF and 
MSP-1 promote cell motility (Wallert and Provost Lab, 2004). 
**Error: One picture of the p53 plate at 9 hours was missing.  
2. Micronuclei Assay 
Materials: 
• (6) 4-chamber well slides 
• 1X PBS [Wash buffer] 
• Carnoy’s fixative: 3:1 methanol : acetic acid 
• DAPI in PBS (1:10 dilution working stock; 1:3000 dilution final) 
• SlowFade Gold with DAPI 
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• Oil immersol with dropper 
• OLYMPUS AX70 Upright Compound Microscope 
Methods: 
 Preparing slides: 
1. After culturing and seeding the cells, add HGF or MSP-1 (50 ng/mL) to their selected 
wells after 1 hour. Then wait for 24 hours. 
2. Irradiate 2 slides (2 Gy.) and another 2 (4 Gy.), leaving 2 slides as control with no 
dosage. 
3. After 48 hours, fix the cells in Carnoy’s fixative.  
4. Wash with PBS three times, with each for 5 minutes. Add DAPI solution (350 µL/well) 
and incubate the slides for 5 minutes. Wash the cells again with PBS three times (five 
minutes each). 
5. Mount each slide by adding 3-4 drops of SlowFade Gold and using a 22x50 mm cover 
glass. Seal each slide with nailpolish on the outer boundary. 
Counting: 
1. Turn on the microscope. 
2. Add one drop of oil immersol on Coverslip. 
3. Touch the 100x objective lenses with the oil and turn on the fluorescence blue light 
4. Count the number of micronuclei and binucleated cells. 
  
 
Analysis: 
Picture 1: A field of view showing 1 binucleated cell 
with one micronuclei. 
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When the fluorescence light is turned on, we counted the blue cells that are binucleated and 
also the ones that have micronuclei (Picture 1). We analyzed the percentage of micronuclei of 
all the binucleated cells to find quantitatively how much damage occurred since micronuclei is 
composed of DNA fragments that are all clumped together. (Genpharmtox).  
3. Apoptosis Assay 
Materials: 
• (6) 4-well chamber well slides 
• 1X PBS [Wash buffer] 
• 4% paraformaldehydeProlong Gold with DAPI 
• 0.5% Triton (Permeabilizing buffer) 
• 3% BSA (Blocking buffer) 
• Primary antibody solution (Cleaved caspase-3, 1:300 dilution in blocking buffer) 
• Secondary antibody solution ( Alexa-Fluor 488 goat anti-rabbit IgG antibody, 1:1000 in 
blocking buffer) 
Methods: 
 Preparing slides: 
1. After culturing and seeding the cells, add HGF or MSP-1 (50 ng/mL) to each selected well 
(based on plate setup) after 1 hour. 
2. After 24 hours, irradiate 2 slides with 2 Gray while and another 2 with 4 Gray, leaving 
two as control with no dosage. After 48 hrs, wash with PBS and fix the cells with 4% 
paraformaldehyde for 10 min. at room temperature. ***  
3. Wash the cells three times for five minutes each with PBS.  
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4. Add 400 µL/well permeabilizing buffer for 3 minutes at room temperature. Add 400 µL 
blocking buffer to each well and incubate for 30 minutes to 1 hour. 
5. Add primary antibody solution and incubate for 1-2 hours at room temperature. Wash 
three times for five minutes each with PBS.  
6. Next, add secondary antibody solution (150 µL/well) and incubate 30 minutes to 1 hour 
at room temperature without being exposed to light.  
7. Wash three times for five minutes each with PBS. Use 3-4 drops of Prolong Gold with 
DAPI/slide, and use 22x50mm cover glass to mount and seal each slide with nail polish. 
Counting: same as in Micronuclei assay except: 
1. Touch the 60x objective lenses with the oil and switch between the blue & green lights 
2. Count positive (green) cells/1000 blue (normal) cells = apoptotic index. 
***If storing, replace paraformaldehyde with PBS and cover with parafilm, and store it at 4° C. 
Analysis: 
For this assay, we counted the positive apoptotic (green) and negative normal (blue) cells to see 
if any cleaved caspase-3 enzymatic activity occurred. For every field of view, we counted the 
number of blue cells first while the blue light is on. Then, we switched to the green light to see 
if any positive cells were there in the same field of view. If there is at least one bright green cell, 
we switched back to the blue light to see if a blue cell is overlapping in the same position to 
clarify if it actually a cell (Picture 2) (Promega, 2011).  
Results 
1. MTT Proliferation and Cytotoxicity 
Picture 2: A field of view showing normal 
(blue) and two apoptotic (green) cells. 
Picture 2: A field of view showing 2 positive 
apoptotic cells and many other blue cells.  
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Proliferation:  The MTT proliferation assay was conducted with 10, 50, or 100 ng/mL 
concentrations of HGF and MSP-1 in both normal and mutated cell lines over a 96-hour period. 
The results present that cell proliferation increased over time in both normal and mutated cells. 
Interestingly, there was no positive or negative effect in both cell lines as the concentrations of 
either drugs (10, 50, and 100ng/mL) increased. When considering HGF and MSP-1, our results 
show that both drugs do not aid in cell proliferation in both normal and mutated epithelial cells 
(Figure 1.1a & 1.1b). 
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Figure 1.1a: The Effect of HGF and MSP at concentrations of 10 ng/mL, 50 ng/mL and 100 
ng/mL over a 96 hour period on normal EPC2-hTERT esophageal epithelial cells.  
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Cytotoxicity:  For the MTT Cytotoxicity assay, the cells were given 2 and 4 Gray dosages of 
gamma radiation with two HGF and MSP-1 (50 or 100 ng/mL) concentrations. The results 
presented in Figures 1.2a & 1.2b show that as radiation dosage increased in both cell lines with 
no drug, the number of EPC2-hTERTdecreased significantly while there was little change in the 
p53-mutated cells. When considering HGF and MSP-1’s effects, they interestingly protected the 
normal cells more than the mutated cells from radiation (Figure 1.2a & 1.2b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1b: The Effect of HGF and MSP at concentrations of 50 ng/mL and 100 ng/mL 
over a 96 hour period on mutated EPC2-hTERT-p53R175H esophageal epithelial cells.  
 
 
Figure 1.2a: The Effect of HGF and MSP (50 and 100 ng/mL) with gamma radiation 
(Cs137) dosages of 2 and 4 Gray at 72 hours on cytotoxicty of irradiated normal 
EPC2-hTERT esophageal epithelial cells.  
 
Figure 1.2b: The Effect of HGF and MSP (50 and 100 ng/mL) with gamma radiation (Cs137) 
dosages of 2 and 4 Gray at 72 hours on cytoxicity of p53-mutated esophageal epithelial cells.  
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2. Wound Healing: This assay allowed us to observe how much normal and mutated cells 
migrated with 50 or 100 ng/mL concentrations of HGF and MSP-1 over a 24 hour period. 
According to the results shown in Figures 2.1 & 2.2, both HGF and MSP-1 enhanced cell 
migration more than the cells with only KBM after 24 hours. To compare overall how 
much the normal and mutated cells migrated with the KBM control, HGF, and MSP-1 
factors, Figure 2.3 is shown after 12 hours of healing. From Figure 2.3, HGF seems to be 
an effective drug in enhancing cell migration in normal cells than in the mutated cells 
since HGF in general increases cell proliferation. What about MSP? 
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Figure 2.1: The Effect of HGF and MSP at concentration of 
50 ng/mL over a 24 hour period on normal EPC2-hTERT 
esophageal epithelial cells. 
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Figure 2.2: The Effect of HGF and MSP at concentration of 
50 ng/mL over a 24 hour period on mutated EPC2-hTERT-
p53R175H esophageal epithelial cells. 
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Figure 2.3: The Effect of KBM control, HGF and MSP (50 
ng/mL) at 12 hours on mutated EPC2-hTERT-p53R175H 
esophageal epithelial cells. 
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3. Micronuclei Assay: The cells were irradiated at 2 and 4 Gray with 50 or 100 ng/mL 
concentrations of HGF and MSP-1. In both figures, radiation seems to cause significant 
cell damage since there was an increase in the percentage of binucleated cells with 
micronuclei in both cell lines as the radiation dosage increased.  Specifically for HGF, 
more micronuclei formed in both types of cells except at 4 Gray for the mutated cells. 
Also, at 2 Gray, both HGF and MSP-1 did not enhance micronuclei formation activity in 
normal cells as much as in the mutated cells (Figures 3.1 & 3.2).  
 
 
 
 
 
 
 
 
 
 
4. Apoptosis Assay: In this assay, we added 50 or 100 ng/mL concentrations of HGF and 
MSP-1 to both cell lines and counted them after 48 hours of radiation exposure (2 or 4 
Gray). According to the results shown in Figures 4.1 & 4.2, as radiation dosage 
increased, the apoptotic activity (programmed cell death) increased in both cell lines in 
Figure 3.1: The Effect of HGF and MSP (50 ng/mL each) 
on normal EPC2-hTERT esophageal epithelial cells with 
0, 2, or 4 Grays of Cs137 gamma radiation. 
 
Figure 3.2: The Effect of HGF and MSP (50 
ng/mL each) on mutated EPC2-hTERT-p53R175H 
esophageal epithelial cells with 0, 200, or 400 
rads (0, 2, 4 Gys.) of Cs137 gamma radiation. 
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respect to the drug added. Without any radiation dosage, HGF and MSP-1 enhanced 
apoptosis (Figures 4.1 & 4.2). Specifically in Figure 4.1, HGF had no/little effect while 
MSP-1 significantly inhibited cell death in the normal cells. In the mutated cells, even 
though there was a little increase in apoptosis at 2 Gray, both HGF and MSP-1 enhanced 
cell death at 4 Gray. MSP-1 in particular, caused more apoptosis than HGF (Figure 4.2). 
 
 
 
 
 
 
 
 
Discussion 
 Our MTT proliferation assay results showed that neither HGF or MSP-1 cause cell 
proliferation in normal and mutated epithelial cells. At these concentrations and times tested, 
the growth factors may not promote proliferation. Additional  explanations include  several 
errors such as possible bacterial contamination, not protecting the plates from light, time 
misalignments, and pippetting errors might have caused this. In the future, conducting more 
runs might give better and consistent results with previous work that has already been done on 
this assay for HGF and MSP-1.  
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Figure 4.1: The Effect of HGF and MSP at concentration 
of 50 ng/mL on normal EPC2-hTERT esophageal 
epithelial cells with 0, 2, or 4 Grays of Cs137 gamma 
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Figure 4.2: The Effect of HGF and MSP at 
concentration of 50 ng/mL on mutated EPC2-hTERT-
p53R175H esophageal epithelial cells with 0, 2, or 4 
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 In the MTT test for cytotoxicity, the normal cells had significant changes in samples with 
and without drug as radiation dosage increased. This supports earlier reports that HGF and 
MSP-1 have protective properties on cells from stress. (Nakamura et. al, 2011) (Wang et. al, 
2003). When HGF or MSP-1 was added, they had significant protection, especially the cells with 
MSP-1 (100 ng/mL). For the p53-mutated cells,  there was no effect of radiation and there were 
little differences even among the cells with HGF or MSP-1. Cancer cells are known to replicate 
fast, especially with the well known p53 mutation. This mutation prevents a cell with DNA 
damage   from undergoing apoptosis, thus allowing it to proliferate. This explains why the 
mutated cells with no drug did not die easily (Vogelstein et al., 2000). If the mutated cells are 
already protecting themselves, then the drugs’ intervention would not make much difference, 
which is clearly shown in the figures. Additionally, if the cells are already programmed to 
proliferate, then the 2 and 4 Gray doses may not be enough to reduce the number of cells and 
observe if HGF and MSP-1 take part in protecting the cells. If the mutated cells are much more 
aggressive than the normal cells, then in the future, higher doses may be used to see better 
results.  
 The wound healing assay showed that both drugs enhanced migration in both cell lines. 
There were positive results in both figures, but might give contradictory information when 
considering the drugs for chemotherapy purposes. HGF and MSP-1’s migration activity was 
higher than the KBM control’s after 24 hours for both cell lines. Previous research has shown 
that HGF’s effect in epidermal keratinocytes (Nakamura et. al, 2011) and MSP-1’s intervention 
in epithelial cancers (Wang et. al, 2003) resulted in similar results. In the normal cells, HGF 
addition resulted in  100% wound healing and MSP-1 addition resulted in 47% wound healing. 
Comment [ZP1]: Do not use words like 
“successful” or “unsuccessful” in terms of 
experiments and data.  The data is what it is, neither 
“right” nor “wrong” 
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In the mutated cells, HGF’s still 100% and MSP-1’s (83%) higher percentage of wound healed 
show that recovery of cancerous cells is occurring.MSP-1 appears to have a greater motogenic 
effect on p53-mutated cells compared to normal epithelial cells, indicating that pre-cancerous 
cell lines are more sensitive to external cues that can lead to migration and invasion (hallmarks 
of cancer) (Ludwig Institute for Cancer Research).Future studies on how HGF and MSP-1’s 
affects other epithelial cancers may show if the trends found in this project is only specific 
toesophageal squamous cell carcinoma.  
 In the micronuclei assay, both figures show that as the radiation dosage increased, cell 
damage increased for the control, HGF, and MSP-1 in both cell lines. Without considering the 
difference in the scales in both figures, all cells with either/no drug increased the percentage of 
micronuclei at 4 Gray compared to the other dosages. Also, considering the difference in the 
scales, there was more cell damage occurring in the mutated cells than in the normal cells. This 
might explain the fact that since all the cells are still living, the radiation causes significant 
damage on cells that do not have cell repair processes that work properly (NIH, 1999). For the 
normal cells, HGF enhanced more cell damage at the highest dose, showing that HGF may not 
be advisable for future chemotherapy treatments. For MSP-1, one study supported our results 
that MSP-1 had a neutral effect on the normal cells (Sifa, 2009).   On the other hand, MSP-1 
caused more cell damage than HGF at the highest dose in the mutated cells, suggesting that 
MSP-1 could be investigated further as a potential drug in cancer research. Even though HGF 
and MSP-1 caused certain trends in both cell lines, more runs on this assay should be done to 
confirm our observations that may account for counting errors and possible contamination with 
the cells. Lastly, both figures present that more micronuclei are forming in the mutated cells 
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than the normal cells (see the scales closely) no matter which drug is used. This observation is 
important since this assay involves with only live cells, it suggests that the pre-cancerous cells 
are surviving with cell damage that can cause further deterioration on the human esophagus. 
Under normal circumstances, the cells that are having significant amounts of damage should be 
undergoing apoptosis (NIH, 1999); however, the p53 mutation prevents this and clearly shows 
that further investigation on this matter is vital (Vogelstein et al., 2000). 
In general, as radiation dosage increased, more apoptotic activity occurred (Camphausen 
et. al, 2001). Even though HGF did not affect the normal cells in any way, the drug promoted 
apoptosis in the mutated cells (especially at 4 Gray). On the other hand, MSP-1 inhibited 
apoptosis in the normal cells significantly while promoting apoptosis at 4 Gray in the mutated 
cells. This supported by a research group’s findings that MSP-1 is known to help epithelial cells 
survive since there was less than 10% apoptotic activity in normal epithelial cell cultures than in 
cultures with only media (Danilkovitch et. al, 1999). HGF and MSP-1 both seem to show 
opposites trends again, as seen in the micronuclei assay. To confirm HGF’s neutrality on 
irradiated normal cells, higher doses should be used in the future to see if that is not the case. 
Also, even though MSP-1 may be thought as a possible drug in future cancer treatments, MSP-1 
did not show major differences at 2 Gray for the mutated cells. More runs on this assay may be 
necessary to see if MSP-1 is only effective to promote apoptosis in ESCC at 4 Gray dose.  
Conclusion 
There were many factors used to investigate HGF and MSP-1’s activities. We used radiation as 
an environmental stress and found that the drugs may be most active only at certain dosages. 
We have found that while 2 and 4 Gray doses are sufficient to cause protection in the normal 
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cells, HGF and MSP-1 seem to need more dosages of radiation have an effect on the p53 cells. 
When forming micronuclei, both drugs enhanced more cell damage in the p53 cells than the 
normal cells, with MSP-1 only causing more at 4 Gray in the p53 cells than the normal hTERT 
cells. In terms of apoptosis, both drugs caused much damage at 4 Gray in the cancerous cells. 
Also, MSP-1 prevented significant cell death as the radiation dosage increased in the normal 
cells. Since radiation has brought both short and long term effects on astronauts in the past 
decades, current investigation is occurring now in finding out the role of certain growth factors 
in radiation-induced esophageal carcinogenesis..   
 
 
 
 
 
